178 related articles for article (PubMed ID: 11168013)
1. Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.
Takenaka K; Fujiyama Y; Andoh A; Sasaki T; Amakata Y; Matsubara H; Hodohara K; Bamba T
Clin Exp Immunol; 2001 Jan; 123(1):155-61. PubMed ID: 11168013
[TBL] [Abstract][Full Text] [Related]
2. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue.
Spiekermann GM; Nagler-Anderson C
J Immunol; 1998 Dec; 161(11):5825-31. PubMed ID: 9834060
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
6. Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells.
Haridas V; Kamat RS
Clin Exp Immunol; 1997 Dec; 110(3):454-63. PubMed ID: 9409651
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal enterotoxin B stimulates expansion of autoreactive T cells that induce apoptosis in intestinal epithelial cells: regulation of autoreactive responses by IL-10.
Ito K; Takaishi H; Jin Y; Song F; Denning TL; Ernst PB
J Immunol; 2000 Mar; 164(6):2994-3001. PubMed ID: 10706687
[TBL] [Abstract][Full Text] [Related]
8. IL-18 prevents the development of chronic graft-versus-host disease in mice.
Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
10. Induction of unresponsiveness to the superantigen staphylococcal enterotoxin B: cyclosporin A resistant split unresponsiveness unfolds in vivo without preceding clonal expansion.
Heeg K; Bendigs S; Miethke T; Wagner H
Int Immunol; 1993 Aug; 5(8):929-37. PubMed ID: 8398987
[TBL] [Abstract][Full Text] [Related]
11. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
[TBL] [Abstract][Full Text] [Related]
12. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
13. Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.
Saloga J; Enk AH; Becker D; Bellinghausen I; Kühn S; Knop J
Immunology; 1998 Apr; 93(4):485-92. PubMed ID: 9659219
[TBL] [Abstract][Full Text] [Related]
14. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
Giese T; Davidson WF
Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin B induces arthritis in female DBA/1 mice but fails to induce activation of type II collagen-reactive lymphocytes.
Omata S; Sasaki T; Kakimoto K; Yamashita U
Cell Immunol; 1997 Aug; 179(2):138-45. PubMed ID: 9268497
[TBL] [Abstract][Full Text] [Related]
16. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
[TBL] [Abstract][Full Text] [Related]
17. The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity.
Wen R; Surman S; Blackman MA; Woodland DL
Cell Immunol; 1997 Mar; 176(2):166-72. PubMed ID: 9073390
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
Ragin MJ; Sahu N; August A
Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
[TBL] [Abstract][Full Text] [Related]
20. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
Hsu LJ; Jan MS; Lin YS
Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
